• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Cold Chain Packaging and Logistics

    How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

    Challenges of Preparing Highly Potent Oral Products

    Bioprocessing Trends

    Sustainable Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    groninger Continues Growth in the US

    Catalent Bolsters Cell and Gene Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    What Does the Future of API Synthesis Look Like?

    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Bolsters Cell and Gene Services

    CDMO Sirio Pharma Completes the Acquisition of Best Formulations

    Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

    Case Study: Secondary Sourcing Strategies to Ensure Supply Chain Security

    Beat the Supply Chain Backlog
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Catalent Bolsters Cell and Gene Services

    Crown Bioscience to Acquire Indivumed’s Service Biz and Supporting Biobank

    Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

    Understanding the Essential Role of a Qualified Person

    Altasciences Los Angeles Clinical Site Receives CAP Accreditation
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    CMC Pharmaceuticals

    INCOG BioPharma Services

    Chiron Recombinant Proteins

    Syngene International Ltd.

    Lannett CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    CMC Pharmaceuticals

    INCOG BioPharma Services

    Chiron Recombinant Proteins

    Syngene International Ltd.

    Lannett CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Like It’s 1999

    Reflecting on 20 years of Contract Pharma.

    Like It’s 1999
    Related CONTENT
    • Contracting And Outsourcing Exhibitor List
    • Legacy Pharma Solutions
    • PCI Pharma Services
    • Asymchem
    • Catalent Pharma Solutions
    Gil Roth, President, Pharma & Biopharma Outsourcing Association10.15.19
    The first time “20 years ago” resonated with me was in 1997, when I was driving to work and passed the movie theater where Star Wars was being re-released. In a flash, I remembered being a 6-year-old kid outside that same theater in 1977, waiting to get in to my first viewing of Star Wars. My old man recognized a pal of his near the front, which enabled us to cut in the line that stretched all the way around the back of the RKO. Since that flashback, the “20 years ago” moments came fast and furious, except with bigger numbers attached, until they segued into “back when I was young” anecdotes.

    But 20 years ago for the origin of Contract Pharma? That one packs a wallop.

    I still remember the afternoon my editorial director walked into my office to say, “I’ve got good news and bad news: the good news is that you don’t work for me anymore; the bad news is that we’re launching a new pharmaceutical magazine and you’re the editor,” and dropped a business plan on my desk.

    At that point, I was managing editor for a cosmetic packaging magazine, with no pharma experience to speak of. I didn’t know about drug manufacturing, outsourcing, clinical trials, formulation development or any of the other good stuff that this magazine would cover. And 1999 wasn’t exactly the golden age of the search engine, so it took a lot of work (with plenty of missteps) to build a ground-level understanding of the sector.

    Knowing so little about the pharma industry overall, I thought the customer side would be happy to talk about how outsourcing and contract manufacturing organizations (CMOs) were giving them a competitive edge in manufacturing, enabling them to focus on R&D and marketing. That lasted until I heard a variation of the same statement from five major pharma companies: “We make what we sell, and we sell what we make.” I knew it wasn’t true; I’d already been to visit [CMO X] and saw a lobby letter board reading, “Welcome, [MAJOR PHARMA COMPANY Y],” but I figured they had their reasons for not talking about their CMOs.

    So instead of working closely with the customer side to understand the dynamics of this industry, I had to talk to the CMOs. Which, you could say, led to the role I now hold, but we’ll get to that later.
    The business plan that was plopped on my desk (I still have it) was written by a pair of publishers from another magazine company who had the idea for Contract Pharma but wanted to make sure it was done right. The plan had in-depth market analysis, a strong list of prospective advertisers, sample editorial topics, a publishing schedule based on major industry trade shows, and multi-year revenue projections. Gary Durr and Damaris Kope had the vision for this magazine, and knew they could make it work.

    Then the editor they were going to bring with them got cold feet and they wound up with me.

    It’s to their enduring credit that they didn’t panic, insist on an editor with pharma-experience, or run back to their company and abort the concept. They were willing to take a chance on a 28-year-old weirdo (let’s be honest), and did their best to get me up to speed.

    I’m forever thankful to them for that, and for everything they taught me over the ~15 years I worked with them.

    The magazine exceeded all expectations in our first years, blasting past the revenue expectations as the ad pages kept coming in and I kept trying to figure out what all these companies DID, exactly. I was insecure enough at that point to believe that everyone else knew what all the acronyms and terminology meant, and that I was the clueless one in the industry. That went away after a few years, which is why we decided to make the annual Glossary of Terms, since it turns out NO ONE knows all this stuff.

    The first 5 or 6 issues were a one-man show, editorially speaking, but as the page counts grew, we brought on staff. Bringing aboard Sarah Madley, our first Associate Editor, helped me step back from some of the routine details of the magazine and try to plan ahead for what that was worth—given the occasional contributed article cancellations and “it seemed like a good topic at the time” ideas I had for staff-written articles. Having an associate also taught me that humans aren’t telepathic and it helps to actually tell them what you want.

    Sarah departed after a few years, and with the arrival of Kristin Brooks fifteen years ago, Contract Pharma really hit its stride. We produced strong editorial, built a can’t-miss conference (that began in 2002, and Kristin’s contributions have been essential to its growth), and cemented Contract Pharma’s position as the premier magazine in the outsourcing space. Kristin’s contributions have been immeasurable and the magazine couldn’t have succeeded without her. Over the years, the Contract Pharma team weathered the financial crash, waves of industry consolidation, and the transition to digital without sacrificing what made the magazine strong. (I also want to thank all the back-office staff at Rodman Media who played a role in the magazine’s success, from Production and Art to Circulation and Online, as well as the office managers, the boss, and my editorial director, who started this whole mess by dropping that plan on me in 1999.)

    It was with some trepidation and sadness that I left at the beginning of 2014 to launch the Pharma & Biopharma Outsourcing Association (PBOA). The idea for it came out of an article I wrote about the Generic Drug User Fee Amendments (GDUFA) in 2013. More than a dozen companies gave me quotes for that article, and every single one of them wanted to stay anonymous, for fear of reprisals with the agency. That’s when I got the idea that this industry needs a voice with FDA (and Congress, as it turns out), and that an association can be a lightning rod of sorts.

    But it wasn’t just a career opportunity for me. I formed PBOA because all those years of working with the CMO/CDMO sector—and I still remember the phone call where JJ Feik of DPT Labs told me we need to add a “D” to make it the CDMO sector, with a focus on development services—brought me up close not just to the companies and what they do for patients, but to the people they employ. I’ve been to some of their weddings and their kids’ graduations, and they’ve been there during some of my tough moments. I care about this sector and the people who work in it.

    Now that I’m running a trade association and registered with the feds as a lobbyist, I tell people that schmoozing is my mutant super-power, but I doubt I would have built all those close relationships without Gary and Damaris bringing me along to meetings and meals, and teaching me how to talk about something besides work (or modernist literature, as was my wont). I was insular, insecure, and aloof when I started out on this magazine, and I probably wouldn’t have taken the time to get to know people without the example they set. I thank them both for all the guidance that enabled me to make this jump. We went through a lot together, and I wish them luck on the next stage of their lives.

    For 20 years, Contract Pharma has championed the bio/pharma outsourcing sector, and the work it does to develop and manufacture medicines for patients in need. I’m honored and proud to have played a role in it. Here’s to another 20 years!


    Gil Roth
    President, Pharma & Biopharma Outsourcing Association

    Gil Roth is the President of the Pharma & Biopharma Outsourcing Association (pharma-bio.org), a nonprofit trade association advocating for the CMO/CDMO sector. He was the Founding Editor of Contract Pharma, serving from 1999 to 2014. He can be reached at gil.roth@pharma-bio.org
    Related Searches
    • patients
    • pharma companies
    • Clinical Trials
    • Outsourcing
    Suggested For You
    Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
    Legacy Pharma Solutions Legacy Pharma Solutions
    PCI Pharma Services PCI Pharma Services
    Asymchem Asymchem
    Catalent Pharma Solutions Catalent Pharma Solutions
    Mogene Mogene
    Regis Custom Pharma Regis Custom Pharma
    Softweb Solutions Softweb Solutions
    Vetio Animal Health Vetio Animal Health
    Adare Pharma Solutions Adare Pharma Solutions
    CONTRACT PHARMA Adds Media Sales Directors CONTRACT PHARMA Adds Media Sales Directors
    Contract Pharma’s 20th Anniversary Retrospective: Drug Development  Contract Pharma’s 20th Anniversary Retrospective: Drug Development
    20 Year Retrospective 20 Year Retrospective
    Contract Pharma’s 20th Anniversary Retrospective Contract Pharma’s 20th Anniversary Retrospective
    VIDEO: Pharma Packaging Solutions VIDEO: Pharma Packaging Solutions' Scott Garverick

    Related Live From Shows

    • Contracting And Outsourcing Exhibitor List

      ...
      09.06.22

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • Drug Development
      PCI Pharma Services

      PCI Pharma Services

      ...
      Tania Moorehead, Global Marketing Manager 10.20.21


    • Asymchem

      Asymchem

      ...
      Mandy Boyd, Asymchem 12.01.20

    • Drug Delivery
      Catalent Pharma Solutions

      Catalent Pharma Solutions

      ...
      Christopher, Director, Global Communications and Marketing 11.25.20

    Loading, Please Wait..
    Trending
    • Sarepta And Catalent Expand Manufacturing Partnership
    • Colorcon Signs Agreement To Purchase Airnov Healthcare Packaging
    • Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
    • The Ongoing Evolution And Implementation Of DCTs In 2023
    • EyePoint Pharmaceuticals To Build GMP Mfg. Facility In Northbridge, MA
    Breaking News
    • Pasithea Signs CMC Development and Manufacturing Agreement
    • Experic Expands Analytical Capabilities and Facilities
    • List Labs Expands Manufacturing Capacity
    • groninger Continues Growth in the US
    • Catalent Bolsters Cell and Gene Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2022

    • Cold Chain Packaging and Logistics
    • Optimizing Supply Chains for Allogeneic Cell Therapy Trials
    • Sustainable Manufacturing
    • Bioprocessing Trends
    • How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login